Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / 5AM Venture Management, LLC
Form 13F · Q2 2026

5AM Venture Management, LLC

CIK 1799883Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$288M
Reported book value
16
Positions
12
Quarters on record
Top 50
Positions

5AM Venture Management, LLC — holdings

Top 16 positions of 16, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1MPLT Maplight Therapeutics Inc950,011+0.0%$34M11.8%
2TYRA Tyra Biosciences Inc1.0M+0.0%$33M11.4%
3TRDA Entrada Therapeutics Inc4.1M+0.0%$30M10.4%
4PHVS Pharvaris N V797,600+0.0%$28M9.6%
5CAMP Camp4 Therapeutics Corp5.9M+0.0%$26M8.9%
6ARTV Artiva Biotherapeutics Inc2.4M+0.0%$23M7.9%
7TECX Tectonic Therapeutic Inc606,660+0.0%$21M7.2%
8ZNTL Zentalis Pharmaceuticals Inc3.9M+0.0%$19M6.7%
9CLDX Celldex Therapeutics Inc New497,270+0.0%$19M6.4%
10EYPT Eyepoint Inc1.1M+0.0%$15M5.2%
11BHVN Biohaven Ltd738,972+0.0%$11M3.8%
12SRZN Surrozen Inc271,250−30.0%$7M2.4%
13SKYE Skye Bioscience Inc9.7M+0.0%$7M2.3%
14ALXO Alx Oncology Hldgs Inc3.1M+0.0%$6M2.2%
15TARA Protara Therapeutics Inc1.4M+0.0%$5M1.8%
16SLN Silence Therapeutics Plc476,200+0.0%$5M1.8%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.